Aeolus Pharma Cash Flow - Annual (OTCMKTS:AOLS)

Add to My Stocks
$0 $0 (0%) AOLS stock closing price Sep 19, 2018 (Closing)

The Aeolus Pharma cash flow statement is one of the three reports that the company generates every quarter. Financials statements like the Aeolus Pharma income statement and Aeolus Pharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Aeolus Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Aeolus Pharma had cash and cash equivalents of $- at the beginning of the year and $3.15M at year end for 2016. Aeolus Pharma had an outflow of $-3.1M from operating activities, $6.17M inflow due to financing activities, and $- outflow due to investing activities for 2016.

View details of Aeolus Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Oct - Sep201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities---0.23M-1.13M--0.51M--0.22M-
Cash From (used in) Discontinued Operations---------
Other Adjustments Net---1.37M-3.5M-2.89M22.73M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-------0.01M--
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------0.52M
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares6.17M--3.61M-1.27M4.37M1.5M-
Issuance (Repayment) of Debt Securities---------
Increase (Decrease) in Bank & Other Borrowings-1M------0.36M-
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities----0.05M-0.01M-0.01M-0.21M-0.09M-0.15M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year-1.51M---2.35M--1.72M
Cash & Equivalents at Year End3.15M-1.51M---2.35M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Aeolus Pharma stock price history and Aeolus Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Aeolus Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $3.06M in 2016. Apart from the Aeolus Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Aeolus Pharma reported a negative operating cash flow of $-3.1M for 2016 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $- for AOLS in last 2016 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $6.17M for Aeolus Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Aeolus Pharma Cash Flow

Annual Cash Flow Statements For Aeolus Pharmaceuticals, Inc. Peers

Cleveland BioLabs cash flow, GelStat cash flow, Respirerx Pharma cash flow, Titan Pharma cash flow